Glenmark Pharmaceuticals Limited (BOM:532296)
India · Delayed Price · Currency is INR 2,099.00
-29.20 (-1.37%)
At close: Sep 15, 2025
Glenmark Pharmaceuticals Employees
Glenmark Pharmaceuticals had 15,800 employees as of March 31, 2025. The number of employees increased by 811 or 5.41% compared to the previous year.
Employees
15,800
Change (1Y)
811
Growth (1Y)
5.41%
Revenue / Employee
8.52M INR
Profits / Employee
477.03K INR
Market Cap
588.45B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 15,800 | 811 | 5.41% |
| Mar 31, 2024 | 14,989 | -567 | -3.64% |
| Mar 31, 2023 | 15,556 | 141 | 0.91% |
| Mar 31, 2022 | 15,415 | 4,451 | 40.60% |
| Mar 31, 2021 | 10,964 | 297 | 2.78% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Reliance Industries | 403,303 |
| HDFC Bank | 214,521 |
| Bharti Airtel | 13,593 |
| Tata Consultancy Services | 607,979 |
| ICICI Bank | 182,665 |
| State Bank of India | 236,226 |
| Infosys | 323,578 |
| Bajaj Finance | 64,092 |
Glenmark Pharmaceuticals News
- 10 days ago - Glenmark Pharma shares jump over 2% after its subsidiary gets $700 million from AbbVie for licensing deal - Business Upturn
- 10 days ago - Glenmark Pharma receives $700 million upfront payment from AbbVie for global licensing deal - Business Upturn
- 14 days ago - Glenmark Pharma initiates multi-country Phase 3 Clinical Trial for Envafolimab in Stage III NSCLC - Business Upturn
- 15 days ago - Bajaj Electricals, UBL& more: Top stocks on brokers' radar today - The Times of India
- 16 days ago - Glenmark Pharma shares jump over 2% as HSBC maintains ‘Buy’ rating with target price of Rs 2,380 - Business Upturn
- 16 days ago - Glenmark Pharma share: HSBC maintains buy with Rs 2,380 target, highlights catalysts in debt reduction and FDA approvals - Business Upturn
- 16 days ago - Stocks to watch on brokerages today, September 3: ITC, Adani Power, Indus Towers, UBL, Glenmark Pharma and more - Business Upturn
- 17 days ago - Glenmark Pharma to launch Eribulin Mesylate Injection in the US market - Business Upturn